Clinical Trial Update: Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial update for treatment of growth failure in children/adolescents with primary IGF-1 deficiency; study terminated with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Disorders

Snippet

Sponsor: Ipsen | Conditions: Growth Disorders | Phase 3 | Status: TERMINATED | Results posted: 2011-06-27